Related content

C-reactive protein and coronary heart disease: Diagnostic and therapeutic implications for primary prevention

By Rifai Nader  

Cardiovascular Toxicology, Vol. 1, Iss. 2, 2001-06 ,pp. : 153-157

Humana Press, Inc

Access to resources Recommend Favorite

C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men

By Laaksonen D.   Niskanen L.   Nyyssönen K.   Punnonen K.   Tuomainen T.-P.   Valkonen V.-P.   Salonen R.   Salonen J.  

Diabetologia, Vol. 47, Iss. 8, 2004-08 ,pp. : 1403-1410

Springer Publishing Company

Access to resources Recommend Favorite

C-reactive protein and coronary events following percutaneous coronary angioplasty

By de Winter R.J.   Koch K.T.   van Straalen J.P.  

ACC Current Journal Review, Vol. 12, Iss. 6, 2003-11 ,pp. : 49-50

Elsevier

Access to resources Recommend Favorite

Changes in serum interleukin-6 and high-sensitivity C-reactive protein levels in patients with acute coronary syndrome and their responses to simvastatin

By Luo Yumei   Jiang Deqian   Wen Dan   Yang Jianxin   Li Liying  

Heart and Vessels, Vol. 19, Iss. 6, 2004-11 ,pp. : 257-262

Springer Publishing Company

Access to resources Recommend Favorite

Do associations with C-reactive protein and extent of coronary artery disease account for the increased cardiovascular risk of renal insufficiency

By Zebrack J.S.   Anderson J.L.   Beddhu S.   for the Intermountain Heart Collaborative Study Group.  

ACC Current Journal Review, Vol. 12, Iss. 5, 2003-09 ,pp. : 30-30

Elsevier

Access to resources Recommend Favorite